March 22, 2024

Abstract 6501: Development and characterization of covalent inhibitors of the RAS-PIK3CA interaction

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract RAS proteins are membrane bound GTPases that when hyperactivated, act as oncogenes through activation of the MAPK Part 1 (Regular Abstracts) ; 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84 (6Suppl): Abstract nr 6501.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Klebba et al. (Fri,) studied this question.

www.synapsesocial.com/papers/68e72e40b6db6435876a84e0 — DOI: https://doi.org/10.1158/1538-7445.am2024-6501

Authors

Joseph E. Klebba

Junko Tamiya

Jinwei Wang

Journals

Cancer Research

Actions

Institutions

Vividion Therapeutics (United States)

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Abstract 6501: Development and characterization of covalent inhibitors of the RAS-PIK3CA interaction

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion